| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |